MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
All content for eHealthTALK NZ is the property of Rebecca McBeth and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
Forte Health - digitising patient onboarding for efficiency, sustainability and patient experience
eHealthTALK NZ
27 minutes
2 weeks ago
Forte Health - digitising patient onboarding for efficiency, sustainability and patient experience
Matt Devonald, Patient Services Manager at Forte Health, discusses the private hospital’s journey from paper to digital patient onboarding with Personify Care. He talks about how this transition has streamlined patient onboarding, improved the patient experience, and contributed to the organisation’s sustainability goals. Matt reflects on the challenges faced when going digital, Forte’s co-design approach and what this successful project enables for the future.
eHealthTALK NZ
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
